| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0076-6879(91)03005-2 |
| P698 | PubMed publication ID | 1762568 |
| P50 | author | Meredith Mudgett-Hunter | Q105036024 |
| P2093 | author name string | H. Oppermann | |
| E. Haber | |||
| J. McCartney | |||
| F. Warren | |||
| M. S. Tai | |||
| J. S. Huston | |||
| P2860 | cites work | BioTechniques | Q4914664 |
| Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 | ||
| Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase | Q26778389 | ||
| Bio/technology | Q27709596 | ||
| Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A | Q27728519 | ||
| Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution | Q27729251 | ||
| Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes | Q27860623 | ||
| Stereochemistry of polypeptide chain configurations | Q28190300 | ||
| Metalloantibodies | Q68347819 | ||
| Expression of mouse immunoglobulin light and heavy chain variable regions in Escherichia coli and reconstitution of antigen-binding activity | Q68360377 | ||
| Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding | Q68564328 | ||
| In vivo tumor targeting of a recombinant single-chain antigen-binding protein | Q68835538 | ||
| Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution | Q68969863 | ||
| Proteolytic dissection of a hapten binding site | Q70388086 | ||
| Single-chain antigen-binding proteins | Q70406917 | ||
| Manganese, calcium, and saccharide binding to concanavalin A, as studied by ultrafiltration | Q71244814 | ||
| Replacing the complementarity-determining regions in a human antibody with those from a mouse | Q28303497 | ||
| Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties | Q29618268 | ||
| Antibody engineering: advances from the use of Escherichia coli expression systems | Q30987852 | ||
| Searching for Peptide Ligands with an Epitope Library | Q33256793 | ||
| Random peptide libraries: a source of specific protein binding molecules | Q33853651 | ||
| Phage antibodies: filamentous phage displaying antibody variable domains | Q34031345 | ||
| Active antibody fragment (Fv) composed of the variable portions of heavy and light chains | Q34213032 | ||
| Stereochemical criteria for polypeptide and protein chain conformations. 3. Helical and hydrogen-bonded polypeptide chains | Q34356954 | ||
| Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda | Q35331370 | ||
| Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli | Q35896400 | ||
| Structure of two pectate lyase genes from Erwinia chrysanthemi EC16 and their high-level expression in Escherichia coli. | Q36260070 | ||
| The immunogenicity of chimeric antibodies | Q36357164 | ||
| Antibody-selectable filamentous fd phage vectors: affinity purification of target genes | Q36434701 | ||
| Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv). | Q36689028 | ||
| Antibody-antigen complexes | Q37943232 | ||
| Preparation of Fv fragment from the mouse myeloma XRPC-25 immunoglobulin possessing antidinitrophenyl activity | Q39086845 | ||
| Ultrafiltration is theoretically equivalent to equilibrium dialysis but much simpler to carry out | Q39194560 | ||
| Complete variable region sequence of a nonfunctionally rearranged kappa light chain transcribed in the nonsecretor P3-X63-Ag8.653 myeloma cell line | Q40565944 | ||
| Three-dimensional structure of an idiotope–anti-idiotope complex | Q41137779 | ||
| Analysis of the repertoire of anti-(4-hydroxy-3-nitro-phenyl)acetyl (NP) antibodies in C 57 BL/6 mice by cell fusion. II. Characterization of idiotopes by monoclonal anti-idiotope antibodies | Q41196929 | ||
| Assembly of a functional immunoglobulin Fv fragment in Escherichia coli | Q41278018 | ||
| A single-chain murine class I major transplantation antigen | Q41696449 | ||
| TGF alpha-anti-Tac(Fv)-PE40: a bifunctional toxin cytotoxic for cells with EGF or IL2 receptors | Q41724389 | ||
| The binding of sodium dodecyl sulphate to various proteins | Q42224561 | ||
| A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. | Q43691134 | ||
| Properties of the Fd fragment from rabbit immunoglobulin G | Q44654597 | ||
| Domain association in immunoglobulin molecules. The packing of variable domains | Q44715886 | ||
| A comparison of strategies to stabilize immunoglobulin Fv-fragments | Q46093365 | ||
| A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin | Q46249887 | ||
| Production of antibodies in transgenic plants | Q46882065 | ||
| Equilibrium and kinetics of the denaturation of a homogeneous human immunoglobulin light chain | Q47937470 | ||
| Reshaping human antibodies: grafting an antilysozyme activity | Q48327351 | ||
| Antibody production in baculovirus-infected insect cells | Q52441844 | ||
| Single chain antibody (SCA) encoding genes: one-step construction and expression in eukaryotic cells | Q52860029 | ||
| Molecular Interactions in β-Lactoglobulin. X. The Stoichiometry of the β-Lactoglobulin Mixed Tetramerization1 | Q53028107 | ||
| The functional expression of antibody Fv fragments in Escherichia coli: improved vectors and a generally applicable purification technique. | Q54700202 | ||
| Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli | Q54701477 | ||
| Escherichia coli secretion of an active chimeric antibody fragment. | Q54748397 | ||
| Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering | Q59062564 | ||
| Recombinant antibodies possessing novel effector functions | Q59068600 | ||
| Dissociation and denaturation equilibria and kinetics of a homogeneous human immunoglobulin Fab fragment | Q67516555 | ||
| Facilitated in vitro refolding of human recombinant insulin-like growth factor I using a solubilizing fusion partner | Q67527727 | ||
| Rapid PCR-cloning of full-length mouse immunoglobulin variable regions | Q67527855 | ||
| Rapid PCR-cloning of full-length mouse immunoglobulin variable regions | Q67527974 | ||
| Folding and interaction of subunits at the antibody combining site | Q67754803 | ||
| Expression of an antibody Fv fragment in myeloma cells | Q68002968 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody binding sites | Q71147970 |
| P304 | page(s) | 46-88 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Methods in Enzymology | Q2076903 |
| P1476 | title | 3 Protein engineering of single-chain Fv analogs and fusion proteins | |
| Protein engineering of single-chain Fv analogs and fusion proteins | |||
| P478 | volume | 203 |
| Q36266269 | A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor. |
| Q37370904 | A conjugate of an anti-midkine single-chain variable fragment to doxorubicin inhibits tumor growth |
| Q35635839 | A fully human scFv phage display library for rapid antibody fragment reformatting |
| Q33743756 | Adnectins: engineered target-binding protein therapeutics |
| Q44560501 | Anti-herbicide single-chain antibody expression confers herbicide tolerance in transgenic plants. |
| Q56897029 | Antibody engineering |
| Q38330765 | Antigen mimicry by an anti-idiotypic antibody single chain variable fragment |
| Q54575677 | Bacterial expression and characterization of an anti-desipramine single-chain antibody fragment. |
| Q36280826 | BiTEs: bispecific antibody constructs with unique anti-tumor activity |
| Q35761299 | Binding of soluble natural ligands to a soluble human T-cell receptor fragment produced in Escherichia coli |
| Q37044147 | Biosynthetic antibody binding sites: Development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315 |
| Q47751085 | Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cells |
| Q40732356 | Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv-F(c) intrabodies |
| Q34313189 | Characterizing protein-protein complexes and oligomers by nuclear magnetic resonance spectroscopy |
| Q51771550 | Cloning and characterization of a single-chain fragment of monoclonal antibody to ACE suitable for lung endothelial targeting |
| Q48072452 | Cloning, expression and characterisation of a single‐chain antibody fragment to the herbicide paraquat |
| Q33714996 | Construction and expression of a bifunctional single-chain antibody against Bacillus cereus p6ores |
| Q73300730 | Construction and expression of antibody targeted plasminogen activator* |
| Q24804173 | Construction and high cytoplasmic expression of a tumoricidal single-chain antibody against hepatocellular carcinoma |
| Q72112278 | Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and tcr fv frameworks are very similar in structure |
| Q64944496 | Delivery of different genes into pre- and post-synaptic neocortical interneurons connected by GABAergic synapses. |
| Q90212096 | Design and Production of Bispecific Antibodies |
| Q54575685 | Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase. |
| Q33715035 | Development of a streptavidin-conjugated single-chain antibody that binds Bacillus cereus spores |
| Q94948582 | Development of novel detection system for sweet potato leaf curl virus using recombinant scFv |
| Q34376314 | Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting. |
| Q77632286 | Down regulation of B cells by immunization with a fusion protein of a self CD20 peptide and a foreign IgG.Fc fragment |
| Q38323258 | Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system |
| Q35180023 | Engineered Antibodies as Pharmacological Tools |
| Q37101581 | Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors |
| Q47960256 | Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments |
| Q27619054 | Filamentous phage infection: crystal structure of g3p in complex with its coreceptor, the C-terminal domain of TolA |
| Q58579050 | Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging |
| Q30827091 | Generation of recombinant antibodies |
| Q74649982 | Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity |
| Q78001100 | High cytoplasmic expression in E. coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen |
| Q54572163 | High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. |
| Q33369878 | High-level expression and characterization of an anti-VEGF165 single-chain variable fragment (scFv) by small ubiquitin-related modifier fusion in Escherichia coli |
| Q27676139 | High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells |
| Q48001921 | Identification of a 37 kDa plant protein that interacts with the turnip mosaic potyvirus capsid protein using anti-idiotypic-antibodies |
| Q30726862 | Immunisation with phage-displayed variable region 2 from meningococcal PorA outer membrane protein induces bactericidal antibodies against Neisseria meningitidis |
| Q34326534 | Immunotherapy of multiple myeloma |
| Q81223521 | Intranasal immunisation using recombinant Lactobacillus johnsonii as a new strategy to prevent allergic disease |
| Q36799146 | Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library |
| Q64967659 | Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging. |
| Q41446541 | Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains |
| Q28534707 | Mechanism of HIV-1 virion entrapment by tetherin |
| Q33381682 | Molecular cloning and characterization of a single-chain variable fragment antibody specific for benzoylecgonine expressed in Escherichia coli |
| Q43709906 | Mono‐ and Bivalent Antibody Fragments Produced in Escherichia coli: Engineering, Folding and Antigen Binding |
| Q34089045 | Multisite association by recombinant proteins can enhance binding selectivity. Preferential removal of immune complexes from serum by immobilized truncated FB analogues of the B domain from staphylococcal protein A |
| Q36532822 | Muscle-directed anti-Aβ single-chain antibody delivery via AAV1 reduces cerebral Aβ load in an Alzheimer's disease mouse model |
| Q41544256 | New protein engineering approaches to multivalent and bispecific antibody fragments |
| Q42211373 | Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody |
| Q35107467 | Overexpression of Eag1 potassium channels in clinical tumours. |
| Q44267439 | Phage-displayed and soluble mouse scFv fragments neutralize rabies virus |
| Q36728754 | Preparation of biologically active single-chain variable antibody fragments that target the HIV-1 gp120 V3 loop. |
| Q34550950 | Preparation of recombinant RNase single-chain antibody fusion proteins |
| Q40827357 | Production and characterization of a bacterial single-chain Fv fragment specific to human truncated midkine |
| Q42834600 | Production of a single-chain variable fragment antibody recognizing type III mutant epidermal growth factor receptor |
| Q33972355 | Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. |
| Q26828935 | Ribosome-inactivating proteins: from plant defense to tumor attack |
| Q36802931 | Selection of linkers for a catalytic single-chain antibody using phage display technology |
| Q47930471 | Similarities in the biodistribution of iodine-labeled anti-Tac single-chain disulfide-stabilized Fv fragment and anti-Tac disulfide-stabilized Fv fragment |
| Q39723264 | Single chain dimers of MASH-1 bind DNA with enhanced affinity |
| Q41719908 | Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity |
| Q71782162 | Solution properties of Escherichia coli-expressed VH domain of anti-neuraminidase antibody NC41 |
| Q34040767 | Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region |
| Q42824736 | The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor |
| Q89700506 | Therapeutic potential of an anti-HER2 single chain antibody-DM1 conjugates for the treatment of HER2-positive cancer |
| Q72208070 | Tumor targeting in a murine tumor xenograft model with the (sFv')2 divalent form of anti-c-erbB-2 single-chain Fv |
| Q52337856 | VLR Recognition of TLR5 Expands the Molecular Characterization of Protein Antigen Binding by Non-Ig-based Antibodies. |
| Q35852647 | scFv antibody: principles and clinical application |
Search more.